OSR HEALTH INC (OSRH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OSRH SEC filings page.
OSR HEALTH INC (OSRH) reported $1.8M in revenue over the twelve months to Jun 30, 2026, down 50.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A large asset base and recapitalized balance sheet coexist with low revenue, heavy operating costs, and persistent cash consumption.
In FY2025, liabilities fell75.9% while equity turned positive at$127.0M , indicating a major balance-sheet recapitalization rather than operating improvement. That strengthening did not improve near-term funding: the current ratio fell to 0.2x while operating cash flow reached-$4.3M .
The $171.2M asset base produced only
The cash-conversion gap is substantial: FY2025 net loss was
Financial Health Signals
We are recalculating OSR HEALTH INC's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
OSR HEALTH INC scores -0.64, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($7.7M) relative to total liabilities ($44.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
OSR HEALTH INC passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
OSR HEALTH INC reported a net loss of $27.1M while operations used $4.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
OSR HEALTH INC reported an operating loss of $18.3M against $506K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
OSR HEALTH INC generated $316K in revenue in Q2 2026. This represents a decrease of 72.2% from the same quarter a year earlier. Against the prior quarter it is down 34.8%.
OSR HEALTH INC's EBITDA was -$670K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 76.7% from the same quarter a year earlier. Against the prior quarter it is up 46.0%.
OSR HEALTH INC reported -$1.0M in net income in Q2 2026. This represents an increase of 80.8% from the same quarter a year earlier. Against the prior quarter it is up 71.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
OSR HEALTH INC held $1.5M in cash against $271K in long-term debt as of Q2 2026, with $15.7M of liabilities due within a year.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
OSR HEALTH INC's gross margin was 27.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 24.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.7 percentage points.
OSR HEALTH INC's ROE was -0.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for Q2 2026.
OSRH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $316K-72.2% | $484K-36.4% | $381K-58.3% | $628K-23.7% | $1.1M+28.8% | $761K-16.4% | $915K | $823K |
| Cost of Revenue | $229K-79.2% | $324K-45.4% | $252K-66.7% | $366K-43.2% | $1.1M+69.8% | $593K-11.6% | $755K | $644K |
| Gross Profit | $87K+164.2% | $160K-5.0% | $130K-18.9% | $262K+46.1% | $33K-85.9% | $169K-29.7% | $160K | $179K |
| R&D Expenses | N/A | $113K+25.5% | N/A | N/A | N/A | $90K+93.0% | N/A | N/A |
| SG&A Expenses | $3.1M-40.7% | $3.8M+24.0% | $6.5M+267.5% | $4.1M+8.5% | $5.3M+52.9% | $3.1M-12.9% | $1.8M | $3.7M+812.6% |
| Operating Income | -$3.0M+42.0% | -$3.7M-25.7% | -$6.4M-295.9% | -$3.8M-6.6% | -$5.2M-62.9% | -$2.9M+11.6% | -$1.6M | -$3.6M |
| EBITDA | -$670K+76.7% | -$1.2M-92.6% | -$4.1M-697.9% | -$1.4M-100.5% | -$2.9M-544.2% | -$645K-65.5% | -$513K | -$707K |
| Interest Expense | $13K-65.6% | $31K+90.4% | $409K+920.3% | $44K+381.3% | $37K+1684.1% | $16K+25523.0% | $40K | $9K |
| Income Tax | -$440K | -$452K | N/A | -$1.3M-827.9% | N/A | N/A | -$451K | -$140K-207.4% |
| Net Income | -$1.0M+80.8% | -$3.5M+69.6% | -$7.2M-258.3% | -$3.2M-1283.3% | -$5.2M-5270.5% | -$11.4M-18752.9% | -$2.0M | -$231K-395.4% |
| EPS (Basic) | -$0.02-200.0% | -$0.09+91.3% | -$0.16+74.2% | -$0.10+93.6% | $0.02+104.9% | -$1.04-73.3% | -$0.62-6100.0% | -$1.56-15700.0% |
| EPS (Diluted) | N/A | -$0.08 | -$0.23 | N/A | N/A | -$1.04 | -$0.62 | -$0.06 |
| Diluted Shares (Avg) | N/A | 34M | N/A | N/A | N/A | 11M | N/A | 4M |
OSRH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $166.6M-10.1% | $172.2M-1.4% | $171.2M-2.3% | $177.3M+747.2% | $185.4M+798.6% | $174.6M+368.3% | $175.2M+378.4% | $20.9M-71.0% |
| Current Assets | $2.9M-0.3% | $2.9M-15.7% | $2.8M+21.1% | $3.2M+7989.8% | $2.9M+1623.4% | $3.5M+4984.8% | $2.3M+10181.9% | $40K-51.9% |
| Cash & Equivalents | $1.5M-5.4% | $1.6M-1.8% | $1.7M+397.8% | $2.2M+17694.3% | $1.6M+1230.1% | $1.6M+43774.0% | $342K+2115.1% | $12K-78.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $594K+198.9% | $462K-37.2% | $196K-78.7% | $185K | $199K | $737K | $922K | N/A |
| Accounts Receivable | $189K-74.6% | $261K-67.1% | $319K-64.7% | $489K | $743K | $795K | $904K | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $29.2M+10.6% | $29.7M+21.8% | $24.9M+2.4% | $25.5M | $26.4M | $24.4M-8.2% | $24.4M-12.3% | N/A |
| Total Liabilities | $41.7M-9.8% | $44.8M+6.0% | $44.2M-75.9% | $43.1M+61.7% | $46.3M+81.2% | $42.3M+1.6% | $183.6M+352.9% | $26.7M-64.2% |
| Current Liabilities | $15.7M-0.8% | $17.9M+28.9% | $17.2M+395.6% | $15.0M+281.4% | $15.9M+363.9% | $13.9M+405.8% | $3.5M+69.9% | $3.9M+256.6% |
| Non-Current Liabilities | $26.0M-14.6% | $26.9M-5.2% | $27.0M-85.0% | $28.1M+23.6% | $30.4M+37.5% | $28.4M-26.9% | $180.1M+367.9% | $22.7M-69.1% |
| Long-Term Debt | $271K | $273K+7.9% | N/A | $0 | N/A | $253K | $498K | N/A |
| Total Equity | $124.9M-10.2% | $127.4M-3.7% | $127.0M+1624.4% | $134.2M+2431.6% | $139.2M+2937.8% | $132.3M+3170.9% | -$8.3M-113.3% | -$5.8M-134.4% |
| Retained Earnings | -$41.0M-35.7% | -$40.1M-31.2% | -$37.2M-93.9% | -$32.3M-461.8% | -$30.2M-515.3% | -$30.6M-609.5% | -$19.2M-390.7% | -$5.8M-134.4% |
OSRH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.4M-401.6% | -$1.0M-1463.9% | -$1.1M-491.1% | -$2.7M-295.0% | -$483K+0.1% | -$64K+87.2% | -$181K+35.2% | -$686K-379.3% |
| Depreciation & Amortization | $2.4M+0.5% | $2.4M+6.7% | $2.3M+108.5% | $2.4M-16.5% | $2.4M-14.9% | $2.3M-22.0% | $1.1M | $2.9M |
| Investing Cash Flow | -$88K+83.3% | $12K-99.0% | -$2.6M-1270.3% | -$727K-396.3% | -$528K-340.7% | $1.2M+423.1% | -$188K-100.5% | $245K |
| Financing Cash Flow | $2.5M+177.4% | $942K+530.7% | $3.2M+898.9% | $4.1M+1117.8% | $891K+245.2% | $149K-44.0% | $322K+100.9% | $338K+69.0% |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | $19.2M-46.7% | $0 |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.
OSRH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.4%+24.5pp | 33.1%+11.0pp | 34.0%+16.5pp | 41.7%+19.9pp | 2.9%-23.5pp | 22.2%-4.2pp | 17.5% | 21.8% |
| Operating Margin | -960.8% | -757.6% | -1674.8% | -605.9% | -460.5% | -383.3% | -176.2% | -433.4% |
| Net Margin | -318.1% | -716.3% | -1900.4% | -508.9% | -460.2% | -1496.5% | -220.9% | -28.1% |
| Return on Equity | -0.8%+3.0pp | -2.7%+5.9pp | -5.7% | -2.4% | -3.8% | -8.6% | N/A | N/A |
| Return on Assets | -0.6%+2.2pp | -2.0%+4.5pp | -4.2%-3.1pp | -1.8%-0.7pp | -2.8%-2.4pp | -6.5%-6.4pp | -1.1% | -1.1%-1.2pp |
| Current Ratio | 0.180.0x | 0.16-0.1x | 0.16-0.5x | 0.21+0.2x | 0.18+0.1x | 0.25+0.2x | 0.67+0.7x | 0.01-0.1x |
| Debt-to-Equity | 0.00-0.3x | 0.000.0x | 0.35 | 0.00 | 0.33 | 0.00 | N/A | N/A |
| Asset Turnover | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.010.0x | 0.000.0x | 0.01 | 0.04 |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: The current ratio is below 1.0 (0.16), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| OSR HEALTH INC OSRH | FY2025 | $2.9M | -$27.1M | N/A | $7.7M | — |
| Apollomics Inc. APLM | FY2025 | $8.5M | -$10.9M | N/A | $65.7M | 30/100 |
| Adaptimmune Therapeutics plc American ADAP | FY2024 | $178.0M | -$70.8M | -39.8% | $14.6M | 46/100 |
| Phio Pharmaceuticals Corp. PHIO | FY2025 | N/A | -$8.7M | N/A | $11.8M | — |
| Aptorum Group Limited APM | FY2025 | N/A | -$1.4M | N/A | $570K | — |
Where OSR HEALTH INC Ranks
Frequently Asked Questions
What is OSR HEALTH INC's annual revenue?
OSR HEALTH INC (OSRH) reported $2.9M in total revenue for fiscal year 2025. This represents a -17.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is OSR HEALTH INC's revenue growing?
OSR HEALTH INC (OSRH) revenue declined by 17.7% year-over-year, from $3.5M to $2.9M in fiscal year 2025.
Is OSR HEALTH INC profitable?
No, OSR HEALTH INC (OSRH) reported a net income of -$27.1M in fiscal year 2025.
What is OSR HEALTH INC's EBITDA?
OSR HEALTH INC (OSRH) had EBITDA of -$9.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is OSR HEALTH INC's gross margin?
OSR HEALTH INC (OSRH) had a gross margin of 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is OSR HEALTH INC's return on equity (ROE)?
OSR HEALTH INC (OSRH) has a return on equity of -21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is OSR HEALTH INC's operating cash flow?
OSR HEALTH INC (OSRH) recorded an outflow of $4.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are OSR HEALTH INC's total assets?
OSR HEALTH INC (OSRH) had $171.2M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does OSR HEALTH INC spend on research and development?
OSR HEALTH INC (OSRH) invested $318K in research and development during fiscal year 2025.
What is OSR HEALTH INC's current ratio?
OSR HEALTH INC (OSRH) had a current ratio of 0.16 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is OSR HEALTH INC's debt-to-equity ratio?
OSR HEALTH INC (OSRH) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is OSR HEALTH INC's return on assets (ROA)?
OSR HEALTH INC (OSRH) had a return on assets of -15.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is OSR HEALTH INC's P/E ratio?
OSR HEALTH INC (OSRH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $7.7M as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is OSR HEALTH INC's price-to-sales ratio?
OSR HEALTH INC (OSRH) trades at 4.3x sales, its market capitalization divided by revenue of $1.8M revenue, trailing 12 months to June 30, 2026. The market capitalization is $7.7M as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does OSR HEALTH INC's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, OSR HEALTH INC (OSRH) held $1.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $4.3M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is OSR HEALTH INC's Altman Z-Score?
OSR HEALTH INC (OSRH) has an Altman Z-Score of -0.64, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is OSR HEALTH INC's Piotroski F-Score?
OSR HEALTH INC (OSRH) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are OSR HEALTH INC's earnings high quality?
OSR HEALTH INC (OSRH) reported a net loss of $27.1M while operations used $4.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can OSR HEALTH INC cover its interest payments?
OSR HEALTH INC (OSRH) reported an operating loss of $18.3M against $506K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.